Please login to the form below

Not currently logged in
Email:
Password:

QuintilesIMS launches European oncology data-gathering initiative

Will collaborate with Bristol-Myers Squibb, Lilly, Merck KGaA and Pfizer
QuintilesIMS

QuintilesIMS has teamed up with four big pharma firms to gather insights into the real-world use of oncology therapies across Europe.

Working with Bristol-Myers Squibb, Lilly, Merck KGaA and Pfizer, the pharma services provider aims to bridge the gaps and inconsistencies in current data to generate a more comprehensive view of the sector.

Currently, treatment-use information in Europe is based on historical data and so only provides a backward-looking view of the area, according to the recently-merged QuintilesIMS.

Along with its partners QuintilesIMS wants to find out how oncology products are used in each country, by which patients, in which indications and in which combinations with other drugs, and so provide greater insight into current clinical practice.

It is hoped the project will generate more timely, consistent and complete data resources for pharma and, ultimately, enable healthcare providers to make better-informed decisions on patient care in future.

Cancer is the second-highest cause of death and morbidity in Europe, with over 1.7 million deaths and three million new diagnoses every year.

Article by
Rebecca Clifford

13th December 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics